Skip to main content

Hepatoblastoma clinical trials at UCSF

14 in progress, 3 open to eligible people

Hepatoblastoma is a rare cancer affecting the liver, often seen in children. UCSF has trials using T cells to study their safety and impact on liver tumors. A separate trial tests flavored oral irinotecan with temozolomide for solid tumors. UCSF also investigates tegavivint for treating recurring solid tumors to determine safe doses.

Showing trials for

Our lead scientists for Hepatoblastoma research studies include .

Last updated: